@wyssinstitutei
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
The Wyss Institute seeks to transform engineering, medicine and the environment by creating new materials and devices using Nature’s design principles.
Harvard University
Joined April 2010
- Tweets12.9K
- Following1.5K
- Followers28.2K
- Likes13.1K
Pinned Tweet
Prior to the Wyss' founding in 2009, a working group at Harvard University assembled envision the future of biomedical engineering. Now, we see the how this foundation led to successful technologies positively impacting human and planet health.
wyss.harvard.edu/media-post/…
Wyss Institute retweeted
Pulling carbon into seawater using engineered bacteria #NBTintheNews via @wyssinstitute wyss.harvard.edu/news/pullin…
Wyss Institute retweeted
Engineered bacterial siderophore production accelerates rock weathering for carbon removal nature.com/articles/s41587-0…
Wyss Institute retweeted
Evolution of botulinum neurotoxin serotype X proteases to induce inflammatory cell death in cancer cells nature.com/articles/s41587-0…
Wyss Institute retweeted
Excited to share a link to our new ms in BioRxiv! It showed that BBB expression of brain shuttle receptors is stable between brain regions, diseases (AD, PD, ALS, HD) and ages in human subjects. Expression between individuals varied > 10x. biorxiv.org/content/10.64898…
Translating protein recognition into DNA single-molecule readout: a nanopore digital immunoassay for sensitive plasma biomarker quantification.
Read it here 🔗 go.acs.org/dYw
Wyss Institute retweeted
Ever wonder what a nervous system would look like if it self-assembled inside a novel being that hadn't faced a history of selection for its organism-level form and function? Or, perhaps you wondered how #Xenobots would look and act, or what their transcriptome would be like, if they had nervous systems?
Well, here's the first step: advanced.onlinelibrary.wiley…
"Engineered Living Systems With Self-Organizing NeuralNetworks: From Anatomy to Behavior and Gene Expression"
Our awesome team: led by @halehf: @LaurieONeill99, @mmsperry, @LPiolopez, @DrPatrickE, and Tiffany Lin.
The @TuftsUniversity and @wyssinstitute press releases are here, for summaries:
now.tufts.edu/2026/03/16/sci…
wyss.harvard.edu/news/toward…
Wyss Institute retweeted
Manufacturing-aware generative models enable petascale synthesis of designed DNA go.nature.com/3NxXt1I
Wyss Institute retweeted
Our grantee @wyssinstitute is harnessing the power of Artificial intelligence to accelerate the development of transformative medicine, diagnostics, and medical devices, ushering in a new era of accuracy and efficiency in healthcare. 👩⚕️💻🧬
wyss.harvard.edu/news/transl…
Wyss Institute retweeted
Digital SHERLOCK: Rapid Detection and Resistance Profiling of Candida auris
dSHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and #antifungalresistance mutations in patient samples in under an hour
@wyssinstitute
#CRISPR #Candida
hubs.li/Q03-Z7S30
Wyss Institute retweeted
Our new publication:
Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells
nature.com/articles/s42003-0…
Wyss Institute retweeted
Engineered base editors with reduced bystander editing through directed evolution - @rmperrotta @geochurch go.nature.com/4qmupbv
Wyss Institute retweeted
PROTON illustrates how AI can propose testable hypotheses and candidate interventions in neurology.
I am grateful to the interdisciplinary team behind this work, supervised by @marinkazitnik:
• @HarvardDBMI: Joaquín Polonuer, @lvvittor, @InakiArango, @_michellemli
• @BrighamWomens: Xinyuan Wang, @snz20, Richard C. Krolewski, @khurana_lab*
• @wyssinstitute: Katharina Meyer, Bogdan Budnik, Shad Morton, Matthew Woodworth, @NinningLiu, @geochurch, @jenny_m_tam*
• @MassGeneralNews: Yingnan He, @sdas617*
• @broadinstitute: @tkam80, @macosko
• @MSKCancerCenter: Dylan Ritter, Jalwa Afroz, Alexander Henderson, @studerl
• @FutureHouseSF: @SGRodriques, @andrewwhite01
• @ClalitInnovate @ClalitHealth: Noa Dagan
• @UniofOxford: David Clifton
Thank you to the funders and supporters of our research, including @ASAP_Research, @BD2Discoveries, @gatesfoundation, @ChanZuckerberg, @harvard_data, @KempnerInst, @rhodes_trust, @ycombinator, and many others. [7/8]
Wyss Institute retweeted
A personalized biomaterial #CancerVaccine just passed its first-in-human test!
Started by Drs. Stephen Hodi and David Mooney's labs at the @wyssinstitute in 2013, the trial showed that the system can be consistently fabricated and applied to patients: bit.ly/3KPfHe0
Wyss Institute retweeted
✂️ #CRISPR research by Dr. George Church (@geochurch) inactivated all 62 copies of porcine endogenous retrovirus.
🐖 Now, eGenesis at @wyssinstitute & @harvardmed builds upon this work to develop safe and effective pig organs for #xenotransplantation: bit.ly/4iAZKV7
Wyss Institute retweeted
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets go.nature.com/4rBC1Z0
Wyss Institute retweeted
💡 Researchers from the @WyssInstitute have showed they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors!
Check out the work from Dr. @NatalieArtzi's lab in PNAS: bit.ly/4oBNqGe
Press release: bit.ly/447OtFD
Wyss Institute retweeted
Researchers harness tumor cells to boost antitumor immunity in preclinical cancer models, in a new @PNASNews study.
Read more: massgeneralbrigham.org/en/ab… pnas.org/doi/10.1073/pnas.24… @NatalieArtzi @wyssinstitute
Wyss Institute retweeted
A nonsurgical brain implant enabled through a cell–electronics hybrid for focal neuromodulation go.nature.com/3JuSNYH
Wyss Institute retweeted
Clinical researchers and bioengineers at SEAS and the @wyssinstitute have developed slowly biodegradable, injectable biomaterial scaffold vaccines that could solve the problem of device infection in patients.
bit.ly/4qGx8xl
Wyss Institute retweeted
We’re excited to share a new multi-year collaboration with @TakedaPharma, building on the success of our first engagement. Under the agreement, Nabla will receive double-digit millions in upfront and research payments and is eligible for success-based payments exceeding $1 billion.
The partnership deploys Nabla’s AI-driven JAM platform across Takeda’s early-stage programs to include de novo design of antibodies in parallel for multiple targets, multispecifics, challenging targets, and other custom therapeutics.
Read more below